Exploring Inequities in Lung Cancer Management: A Comprehensive Spatio-Temporal Study of Multidisciplinary Meeting Presentations, Supportive Care Assessments, and Diagnostic Timeliness in Victoria - Top-Institutions - MDSpire

Exploring Inequities in Lung Cancer Management: A Comprehensive Spatio-Temporal Study of Multidisciplinary Meeting Presentations, Supportive Care Assessments, and Diagnostic Timeliness in Victoria

  • By

  • Getayeneh Antehunegn Tesema

  • Rob G. Stirling

  • Zemenu Tadesse Tessema

  • Arul Earnest

  • February 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, Victoria

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Cancer Epidemiology
    • Health Services Research

  • #2

    University of Melbourne - Department of Medicine, Royal Melbourne Hospital
    University of Melbourne - Department of Medicine, Royal Melbourne Hospital

    Melbourne, Victoria

    Key Differentiators

    • Pulmonology
    • Thoracic Oncology
    • Epidemiology
    • Biostatistics

  • #3

    Monash University - School of Public Health and Preventive Medicine
    Monash University - School of Public Health and Preventive Medicine

    Melbourne, Victoria

    Key Differentiators

    • Public Health
    • Cancer Epidemiology
    • Health Services Research

  • #4

    Austin Health - Olivia Newton-John Cancer Research Institute
    Austin Health - Olivia Newton-John Cancer Research Institute

    Melbourne, Victoria

    Key Differentiators

    • Medical Oncology
    • Cancer Research
    • Supportive Care

Original Source(s)

Exploring Inequities in Lung Cancer Management: A Comprehensive Spatio-Temporal Study of Multidisciplinary Meeting Presentations, Supportive Care Assessments, and Diagnostic Timeliness in Victoria

  • by Getayeneh Antehunegn Tesema, Rob G. Stirling, Zemenu Tadesse Tessema, Arul Earnest

  • February 27, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma